Randall Schreck
Impact in
- Hepatology top 2%
- Liver physiology and pathology
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Angiogenesis and VEGF in Cancer 5
- PI3K/AKT/mTOR signaling in cancer 2
- Oncology 5
- Cancer Treatment and Pharmacology 3
- Co-authors
- Gerald McMahon (4 shared papers)Cho Tang (4 shared papers)Li Sun (4 shared papers)Laura K. Shawver (2 shared papers)Werner Risau (2 shared papers)Thomas Powell (2 shared papers)K. Peter Hirth (1 shared paper)T. Annie T. Fong (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (2 papers)Journal of Immunotherapy (1 paper)The Journal of Clinical Endocrinology & Metabolism (1 paper)Journal of Clinical Oncology (1 paper)Journal of Allergy and Clinical Immunology (1 paper)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Randall Schreck
13 papers receiving 2.3k citations
Randall Schreck's Hit Papers
Peers
Comparison fields: 5 of 88
- Hepatology 297
- Cancer Research 436
- Oncology 627
- Molecular Biology 1.4k
- Toxicology 54
Countries citing papers authored by Randall Schreck
This map shows the geographic impact of Randall Schreck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Randall Schreck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Randall Schreck more than expected).
Fields of papers citing papers by Randall Schreck
This network shows the impact of papers produced by Randall Schreck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Randall Schreck. The network helps show where Randall Schreck may publish in the future.
Co-authors
The 25 scholars most cited alongside Randall Schreck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. Hit paper breakdown → | 1999 | 920 |
| 2 | A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo. | 2003 | 436 |
| 3 | Flk-1 as a target for tumor growth inhibition. | 1996 | 293 |
| 4 | 1999 | 220 | |
| 5 | The angiogenesis inhibitor SU5416 has long-lasting effects on vascular endothelial growth factor receptor phosphorylation and function. | 2000 | 179 |
| 6 | 1994 | 101 | |
| 7 | 2000 | 101 | |
| 8 | High levels of HER-2 expression alter the ability of epidermal growth factor receptor (EGFR) family tyrosine kinase inhibitors to inhibit EGFR phosphorylation in vivo. | 2001 | 62 |
| 9 | 1995 | 49 | |
| 10 | 1989 | 7 | |
| 11 | 2005 | 4 | |
| 12 | 2011 | 3 | |
| 13 | 2006 | 2 |
About Randall Schreck
Randall Schreck is a scholar working on Molecular Biology, Oncology, Cancer Research, Radiology, Nuclear Medicine and Imaging and Cell Biology, having authored 13 papers that have together received 2.4k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (5 papers), Cancer Treatment and Pharmacology (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Immune Cell Function and Interaction (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Cancer Mechanisms and Therapy (1 paper) and Estrogen and related hormone effects (1 paper). The work is most often cited by research in Hepatology (297 citations), Cancer Research (436 citations), Oncology (627 citations), Molecular Biology (1.4k citations) and Toxicology (54 citations). Randall Schreck has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Gerald McMahon, Cho Tang, Li Sun, Laura K. Shawver, Werner Risau, Thomas Powell, K. Peter Hirth, T. Annie T. Fong, A. Ullrich and Xueyan Wang. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of Immunotherapy, The Journal of Clinical Endocrinology & Metabolism, Journal of Clinical Oncology and Journal of Allergy and Clinical Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.